Mitrov-Winkelmolen, L. et al. The effect of Roux-en-Y gastric bypass surgery in morbidly obese patients on pharmacokinetics of (acetyl) salicylic acid and omeprazole: the ERY-PAO study. Obes. Surg. 26, 2051–2058 (2016).

Article 
PubMed 

Google Scholar 

Miedziaszczyk, M., Ciabach, P. & Szałek, E. The effects of bariatric surgery and gastrectomy on the absorption of drugs, vitamins, and mineral elements. Pharmaceutics 13, 2111 (2021).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Valgimigli, M. et al. Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial. Eur. Heart J. 38, 804–810 (2017).

CAS 
PubMed 

Google Scholar 

Abraham, N. S. et al. American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: management of anticoagulants and antiplatelets during acute gastrointestinal bleeding and the periendoscopic period. J. Can. Assoc. Gastroenterol. 5, 100–101 (2022).

Article 
PubMed 
PubMed Central 

Google Scholar 

Mehran, R. et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. Eur. Heart J. 30, 1457–1466 (2009).

Article 
PubMed 
PubMed Central 

Google Scholar 

Yasuda, H. et al. Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy. World J. Crit. Care Med. 4, 40–46 (2015).

Article 
PubMed 
PubMed Central 

Google Scholar 

Abrignani, M. G. et al. Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO). Eur. J. Intern. Med. 85, 1–13 (2021).

Article 
CAS 
PubMed 

Google Scholar 

Kido, K. & Scalese, M. J. Management of oral anticoagulation therapy after gastrointestinal bleeding: whether to, when to, and how to restart an anticoagulation therapy. Ann. Pharmacother. 51, 1000–1007 (2017).

Article 
CAS 
PubMed 

Google Scholar 

Scott, M. J., Veitch, A. & Thachil, J. Reintroduction of anti‐thrombotic therapy after a gastrointestinal haemorrhage: if and when? Br. J. Haematol. 177, 185–197 (2017).

Article 
PubMed 

Google Scholar 

Sengupta, N. et al. Management of patients with acute lower gastrointestinal bleeding: an updated ACG guideline. Am. J. Gastroenterol. 118, 208–231 (2023).

Article 
PubMed 

Google Scholar 

Abraham, N. S. et al. American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: management of anticoagulants and antiplatelets during acute gastrointestinal bleeding and the periendoscopic period. Am. J. Gastroenterol. 117, 542–558 (2022).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Tomaselli, G. F. et al. 2020 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. 76, 594–622 (2020).

Article 
CAS 
PubMed 

Google Scholar 

European Association for the Study of the Liver EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J. Hepatol. 76, 1151–1184 (2022).

Article 

Google Scholar 

Sandercock, P. A., Counsell, C., Gubitz, G. J. & Tseng, M. C. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst. Rev. 1, CD000029 (2022).

Google Scholar 

Zafar, M. U., Farkouh, M. E., Fuster, V. & Chesebro, J. H. Crushed clopidogrel administered via nasogastric tube has faster and greater absorption than oral whole tablets. J. Interv. Cardiol. 22, 385–389 (2009).

Article 
PubMed 

Google Scholar 

Parodi, G. et al. Ticagrelor crushed tablets administration in STEMI patients: the MOJITO study. J. Am. Coll. Cardiol. 65, 511–512 (2015).

Article 
PubMed 

Google Scholar 

Rollini, F. et al. Crushed prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary intervention: the CRUSH Study. J. Am. Coll. Cardiol. 67, 1994–2004 (2016).

Article 
CAS 
PubMed 

Google Scholar 

Vlachojannis, G. J. et al. Effect of prehospital crushed prasugrel tablets in patients with ST-segment-elevation myocardial infarction planned for primary percutaneous coronary intervention: the randomized COMPARE CRUSH trial. Circulation 142, 2316–2328 (2020).

Article 
CAS 
PubMed 

Google Scholar 

Gargiulo, G. et `al. Cangrelor, tirofiban, and chewed or standard prasugrel regimens in patients with ST-segment-elevation myocardial infarction: primary results of the FABOLUS-FASTER trial. Circulation 142, 441–454 (2020).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Angiolillo, D. J. et al. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery. JAMA 307, 265–274 (2012).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Vaduganathan, M. et al. Cangrelor with and without glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention. J. Am. Coll. Cardiol. 69, 176–185 (2017).

Article 
CAS 
PubMed 

Google Scholar 

Ferreira Silva, R. & Rita Carvalho Garbi Novaes, M. Interactions between drugs and drug-nutrient in enteral nutrition: a review based on evidences. Nutr. Hosp. 30, 514–518 (2014).

PubMed 

Google Scholar 

Klang, M., Graham, D. & McLymont, V. Warfarin bioavailability with feeding tubes and enteral formula. JPEN J. Parenter. Enter. Nutr. 34, 300–304 (2010).

Article 
CAS 

Google Scholar 

Hankey, G. J. & Eikelboom, J. W. Dabigatran etexilate: a new oral thrombin inhibitor. Circulation 123, 1436–1450 (2011).

Article 
PubMed 

Google Scholar 

Peterson, J. J. & Hoehns, J. D. Administration of direct oral anticoagulants through enteral feeding tubes. J. Pharm. Technol. 32, 196–200 (2016).

Article 
CAS 
PubMed Central 

Google Scholar 

Duchin, K. et al. An open-label crossover study of the pharmacokinetics of the 60-mg edoxaban tablet crushed and administered either by a nasogastric tube or in apple puree in healthy adults. Clin. Pharmacokinet. 57, 221–228 (2018).

Article 
CAS 
PubMed 

Google Scholar 

Moore, K. T. et al. Rivaroxaban crushed tablet suspension characteristics and relative bioavailability in healthy adults when administered orally or via nasogastric tube. Clin. Pharmacol. Drug. Dev. 3, 321–327 (2014).

Article 
CAS 
PubMed 

Google Scholar 

Hobl, E. L. et al. Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial. J. Am. Coll. Cardiol. 63, 630–635 (2014).

Article 
CAS 
PubMed 

Google Scholar 

McEvoy, J. W. et al. Effect of intravenous fentanyl on ticagrelor absorption and platelet inhibition among patients undergoing percutaneous coronary intervention: the PACIFY randomized clinical trial (Platelet Aggregation With Ticagrelor Inhibition and Fentanyl). Circulation 137, 307–309 (2018).

Article 
CAS 
PubMed 

Google Scholar 

Iglesias, J. F. et al. Effects of fentanyl versus morphine on ticagrelor-induced platelet inhibition in patients with ST-segment elevation myocardial infarction: the PERSEUS randomized trial. Circulation 142, 2479–2481 (2020).

Article 
CAS 
PubMed 

Google Scholar 

Tavenier, A. H. et al. Impact of opioids on P2Y12 receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial. Eur. Heart J. Cardiovasc. Pharmacother. 8, 4–12 (2022).

Article 
PubMed 

Google Scholar 

Fernando, H. et al. Effects of lignocaine vs. opioids on antiplatelet activity of ticagrelor: the LOCAL trial. Eur. Heart J. 42, 4025–4036 (2021).

Article 
CAS 
PubMed 

Google Scholar 

Fernando, H. et al. Lidocine versus opioids in myocardial infarction: the AVOID-2 randomized controlled trial. Eur. Heart J. Acute Cardiovasc. Care 12, 2–11 (2023).

Article 
PubMed 

Google Scholar 

Holm, M. et al. The MOVEMENT trial. J. Am. Heart Assoc. 8, e010152 (2019).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Franchi, F. et al. Effects of methylnaltrexone on ticagrelor-induced antiplatelet effects in coronary artery disease patients treated with morphine. JACC Cardiovasc. Interv. 12, 1538–1549 (2019).

Article 
PubMed 

Google Scholar 

Niezgoda, P. et al. Oral naloxone to overcome the morphine effect in acute coronary syndrome patients treated with ticagrelor – NARCOTIC trial. Cardiol. J. 29, 432–440 (2022).

Article 
PubMed 
PubMed Central 

Google Scholar 

Sikora, J. et al. Metoclopramide administration as a strategy to overcome morpHine-ticagrelor interaction in patients with unstable angina pectorIs – the METAMORPHOSIS trial. Thromb. Haemost. 118, 2126–2133 (2018).

Article 
PubMed 

Google Scholar 

Saad, M. et al. Impact of morphine treatment with and without metoclopramide coadministration on ticagrelor-induced platelet inhibition in acute myocardial infarction: the randomized MonAMI trial. Circulation 141, 1354–1356 (2020).

Article 
PubMed 

Google Scholar 

Siller-Matula, J. M. et al. Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients. Br. J. Clin. Pharmacol. 82, 1343–1350 (2016).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Zwart, B. et al. Use of glycoprotein IIb/IIIa antagonists to prevent stent thrombosis in morphine-treated patients with ST-elevation myocardial infarction. Platelets 31, 174–178 (2020).

Article 
CAS 
PubMed 

Google Scholar 

Wong, G. C. et al. 2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology guidelines on the acute management of ST-elevation myocardial infarction: focused update on regionalization and reperfusion. Can. J. Cardiol. 35, 107–132 (2019).

Article 
PubMed 

Google Scholar 

Byrne, R. A. et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur. Heart J. 44, 3720–3826 (2023).

Article 
CAS 
PubMed 

Google Scholar 

Droppa, M., Karathanos, A., Gawaz, M. & Geisler, T. Individualised dual antiplatelet therapy in a patient with short bowel syndrome after acute myocardial infarction with coronary artery stenting. BMJ Case Rep. 2015, bcr2014205227 (2015).

Article 
PubMed 
PubMed Central 

Google Scholar 

Koltai, K., Kesmarky, G., Feher, G., Tibold, A. & Toth, K. Platelet aggregometry testing: molecular mechanisms, techniques and clinical implications. Int. J. Mol. Sci. 18, 1803 (2017).

Article 
PubMed 
PubMed Central 

Google Scholar 

Yan, H. et al. The relationship among intestinal bacteria, vitamin K and response of vitamin K antagonist: a review of evidence and potential mechanism. Front. Med. 9, 829304 (2022).

Article 

Google Scholar 

Sobieraj, D. M., Wang, F. & Kirton, O. C. Warfarin resistance after total gastrectomy and Roux-en-Y esophagojejunostomy. Pharmacotherapy 28, 1537–1541 (2008).

Article 
PubMed 

Google Scholar 

Strong, A. T. et al. Adjustments to warfarin dosing after gastric bypass and sleeve gastrectomy. Surg. Obes. Relat. Dis. 14, 700–706 (2018).

Article 
PubMed 

Google Scholar 

Grymonprez, M. et al. Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study. Eur. Heart J. Cardiovasc. Pharmacother. 9, 722–730 (2023).

Article 
PubMed 

Google Scholar 

Cheung, Y. W. et al. Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: the PDER PAN study. Thromb. Res. 160, 76–82 (2017).

Article 
CAS 
PubMed 

Google Scholar 

Grainger, B. et al. Evidence of impaired dabigatran absorption following laparoscopic Roux-en-Y gastric bypass surgery: the Auckland regional experience (2011-2018). Br. J. Haematol. 191, e67–e69 (2020).

Article 
CAS 
PubMed 

Google Scholar 

Christensen, L. D., Vinter-Jensen, L., Rasmussen, H. H., Kristensen, S. R. & Larsen, T. B. Rivaroxaban as anticoagulant therapy in short bowel syndrome. Report of three cases. Thromb. Res. 135, 568–570 (2015).

Article 
CAS 
PubMed 

Google Scholar 

Kröll, D. et al. Pharmacokinetics and pharmacodynamics of single doses of rivaroxaban in obese patients prior to and after bariatric surgery. Br. J. Clin. Pharmacol. 83, 1466–1475 (2017).

Article 
PubMed 
PubMed Central 

Google Scholar 

Steele, K. E. et al. The APB study: apixaban pharmacokinetics in bariatric patients before to 1 year after vertical sleeve gastrectomy or Roux-en-Y gastric bypass. Surg. Obes. Relat. Dis. 18, 594–603 (2022).

Article 
PubMed 

Google Scholar 

Hakeam, H. A. & Al-Sanea, N. Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs). J. Thromb. Thrombolysis 43, 343–351 (2017).

Article 
CAS 
PubMed 

Google Scholar 

Colquitt, J. L., Pickett, K., Loveman, E. & Frampton, G. K. Surgery for weight loss in adults. Cochrane Database Syst. Rev. 2014, CD003641 (2014).

PubMed 
PubMed Central 

Google Scholar 

Angrisani, L. et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes. Surg. 27, 2279–2289 (2017).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Kingma, J. S. et al. Oral drug dosing following bariatric surgery: general concepts and specific dosing advice. Br. J. Clin. Pharmacol. 87, 4560–4576 (2021).

Article 
CAS 
PubMed 

Google Scholar 

Azran, C. et al. Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations. Obes. Rev. 17, 1050–1066 (2016).

Article 
PubMed 

Google Scholar 

Rocca, B. et al. Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis. Eur. Heart J. 39, 1672–1686f (2018).

Article 
CAS 
PubMed 

Google Scholar 

Norgard, N. B., Monte, S. V., Fernandez, S. F. & Ma, Q. Aspirin responsiveness changes in obese patients following bariatric surgery. Cardiovasc. Ther. 35, e12268 (2017).

Article 

Google Scholar 

Caruana, J. A., McCabe, M. N., Smith, A. D., Panemanglore, V. P. & Sette Camara, D. Risk of massive upper gastrointestinal bleeding in gastric bypass patients taking clopidogrel. Surg. Obes. Relat. Dis. 3, 443–445 (2007).

Article 
PubMed 

Google Scholar 

Patel, P. H., Ho, T. & Upadhyay, S. M. A systematic review of warfarin use in post-bariatric surgery patients: cases compiled from a literature review. Ann. Pharmacother. 57, 193–197 (2023).

Article 
CAS 
PubMed 

Google Scholar 

Rottenstreich, A., Barkai, A., Arad, A., Raccah, B. H. & Kalish, Y. The effect of bariatric surgery on direct-acting oral anticoagulant drug levels. Thrombosis Res. 163, 190–195 (2018).

Article 
CAS 

Google Scholar 

Leong, R., Chu, D. K., Crowther, M. A. & Mithoowani, S. J. Direct oral anticoagulants after bariatric surgery — what is the evidence? Thromb. Haemost. 20, 1988–2000 (2022).

Article 
CAS 

Google Scholar 

Kröll, D. et al. Efficacy and safety of rivaroxaban for postoperative thromboprophylaxis in patients after bariatric surgery. JAMA Netw. Open. 6, e2315241 (2023).

Article 
PubMed 
PubMed Central 

Google Scholar 

Martin, K. A. et al. Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation. J. Thromb. Haemost. 19, 1874–1882 (2021).

Article 
PubMed 

Google Scholar 

Decousus, H. et al. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest 139, 69–79 (2011).

Article 
PubMed 

Google Scholar 

Sostres, C., Gargallo, C. J. & Lanas, A. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res. Ther. 15, S3 (2013).

Article 
PubMed 
PubMed Central 

Google Scholar 

Masclee, G. M. et al. Risk of upper gastrointestinal bleeding from different drug combinations. Gastroenterology 147, 784–792.e9 (2014).

Article 
CAS 
PubMed 

Google Scholar 

Rostom, A. et al. Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review. Clin. Gastroenterol. Hepatol. 5, 818–828 (2007).

Article 
PubMed 

Google Scholar 

Ray, W. A. et al. Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding. JAMA 320, 2221–2230 (2018).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Lanas, A., Wu, P., Medin, J. & Mills, E. J. Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis. Clin. Gastroenterol. Hepatol. 9, 762–768.e6 (2011).

Article 
CAS 
PubMed 

Google Scholar 

Lanza, F. L., Royer, G. L. Jr. & Nelson, R. S. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N. Engl. J. Med. 303, 136–138 (1980).

Article 
CAS 
PubMed 

Google Scholar 

Petroski, D. Endoscopic comparison of three aspirin preparations and placebo. Clin. Ther. 15, 314–320 (1993).

CAS 
PubMed 

Google Scholar 

Clerici, B. & Cattaneo, M. Pharmacological efficacy and gastrointestinal safety of different aspirin formulations for cardiovascular prevention: a narrative review. J. Cardiovasc. Dev. Dis. 10, 137 (2023).

CAS 
PubMed 
PubMed Central 

Google Scholar 

Sleem, A. et al. Effectiveness and safety of enteric-coated vs uncoated aspirin in patients with cardiovascular disease: a secondary analysis of the ADAPTABLE randomized clinical trial. JAMA Cardiol. 8, 1061–1069 (2023).

Article 
PubMed 
PubMed Central 

Google Scholar 

Mehta, S. R. et al. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N. Engl. J. Med. 363, 930–942 (2010).

Article 
PubMed 

Google Scholar 

Carnicelli, A. P. et al. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex. Circulation 145, 242–255 (2022).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Xu, Y. & Siegal, D. M. Anticoagulant-associated gastrointestinal bleeding: framework for decisions about whether, when and how to resume anticoagulants. J. Thromb. Haemost. 19, 2383–2393 (2021).

Article 
PubMed 

Google Scholar 

Costa, F. et al. Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI. Eur. Heart J. Cardiovasc. Pharmacother. 8, 216–226 (2022).

Article 
PubMed 

Google Scholar 

Urban, P. et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk. Eur. Heart J. 40, 2632–2653 (2019).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Lv, M. et al. A new score for predicting acute gastrointestinal bleeding in patients administered oral antiplatelet drugs. Front. Pharmacol. 11, 571605 (2020).

Article 
CAS 
PubMed 

Google Scholar 

Bikdeli, B. et al. Clinical characteristics, time course, and outcomes of major bleeding according to bleeding site in patients with venous thromboembolism. Thromb. Res. 211, 10–18 (2022).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Catella, J. et al. Major gastrointestinal bleeding in patients receiving anticoagulant therapy for venous thromboembolism. Thromb. Res. 214, 29–36 (2022).

Article 
CAS 
PubMed 

Google Scholar 

Mo, C. et al. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries. World J. Gastroenterol. 21, 5382–5392 (2015).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Bhatt, D. L. et al. Clopidogrel with or without omeprazole in coronary artery disease. N. Engl. J. Med. 363, 1909–1917 (2010).

Article 
CAS 
PubMed 

Google Scholar 

Ng, F. H. et al. Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. Gastroenterology 138, 82–88 (2010).

Article 
CAS 
PubMed 

Google Scholar 

Ng, F. H. et al. Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction. Am. J. Gastroenterol. 107, 389–396 (2012).

Article 
CAS 
PubMed 

Google Scholar 

Chan, F. K. et al. Similar efficacy of proton-pump inhibitors vs H2-receptor antagonists in reducing risk of upper gastrointestinal bleeding or ulcers in high-risk users of low-dose aspirin. Gastroenterol 152, 105–110.e1 (2017).

Article 
CAS 

Google Scholar 

Levine, G. N. et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines: an update of the ACCF/AHA/SCAI guideline for percutaneous coronary intervention, 2011 ACCF/AHA guideline for coronary artery bypass graft surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF/AHA guideline for the management of st-elevation myocardial infarction, 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation 134, e123–e155 (2016).

PubMed 

Google Scholar 

Virani, S. S. et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation 148, e9–e119 (2023).

Article 
PubMed 

Google Scholar 

Moayyedi, P. et al. Pantoprazole to prevent gastroduodenal events in patients receiving rivaroxaban and/or aspirin in a randomized, double-blind, placebo-controlled trial. Gastroenterology 157, 403–412.e5 (2019).

Article 
CAS 
PubMed 

Google Scholar 

Weisz, G. et al. Proton pump inhibitors, platelet reactivity, and cardiovascular outcomes after drug-eluting stents in clopidogrel-treated patients: the ADAPT-DES study. Circ. Cardiovasc. Interv. 8, e001952 (2015).

Article 
CAS 
PubMed 

Google Scholar 

Dunn, S. P. et al. Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials. J. Am. Heart Assoc. 2, e004564 (2013).

Article 
PubMed 
PubMed Central 

Google Scholar 

Charlot, M. et al. Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study. Ann. Intern. Med. 153, 378–386 (2010).

Article 
PubMed 

Google Scholar 

Demcsák, A. et al. PPIs are not responsible for elevating cardiovascular risk in patients on clopidogrel – a systematic review and meta-analysis. Front. Physiol. 9, 1550 (2018).

Article 
PubMed 
PubMed Central 

Google Scholar 

Marx, N. et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC). Eur. Heart J. 44, 4043–4140 (2023).

Article 
CAS 
PubMed 

Google Scholar 

Agewall, S. et al. Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy. Eur. Heart J. 34, 1708–1713 (2013).

Article 
PubMed 

Google Scholar 

Reddy, V. Y. et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA 312, 1988–1998 (2014).

Article 
PubMed 

Google Scholar 

Holmes, D. R. Jr. et al. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J. Am. Coll. Cardiol. 64, 1–12 (2014).

Article 
PubMed 

Google Scholar 

Osmancik, P. et al. Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation. J. Am. Coll. Cardiol. 75, 3122–3135 (2020).

Article 
CAS 
PubMed 

Google Scholar 

Caliskan, E. et al. Interventional and surgical occlusion of the left atrial appendage. Nat. Rev. Cardiol. 14, 727–743 (2017).

Article 
PubMed 

Google Scholar 

Costa, R. A. et al. Polymer-free biolimus A9-coated stents in the treatment of de novo coronary lesions: 4- and 12-month angiographic follow-up and final 5-year clinical outcomes of the prospective, multicenter biofreedom FIM clinical trial. JACC Cardiovasc. Interv. 9, 51–64 (2016).

Article 
PubMed 

Google Scholar 

Hamon, M. et al. Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study. EuroIntervention 8, 1006–1011 (2013).

Article 
PubMed 

Google Scholar 

Bikdeli, B. et al. Inferior vena cava filters to prevent pulmonary embolism: systematic review and meta-analysis. J. Am. Coll. Cardiol. 70, 1587–1597 (2017).

Article 
PubMed 
PubMed Central 

Google Scholar 

Bikdeli B., et al. Developmental or procedural vena cava interruption and venous thromboembolism: a review. Semin. Thromb. Hemost. https://doi.org/10.1055/s-0043-1777991 (2024).

De Caterina, R. et al. Great debate: triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week. Eur. Heart J. 43, 3512–3527 (2022).

Article 
PubMed 

Google Scholar 

Gargiulo, G. et al. Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials. Eur. Heart J. 40, 3757–3767 (2019).

Article 
CAS 
PubMed 

Google Scholar 

Alexander, J. H. et al. Risk/benefit tradeoff of antithrombotic therapy in patients with atrial fibrillation early and late after an acute coronary syndrome or percutaneous coronary intervention: insights from AUGUSTUS. Circulation 141, 1618–1627 (2020).

Article 
PubMed 

Google Scholar 

Vranckx, P. et al. Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial. Lancet 394, 1335–1343 (2019).

Article 
CAS 
PubMed 

Google Scholar 

Lopes, R. D. et al. Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N. Engl. J. Med. 380, 1509–1524 (2019).

Article 
CAS 
PubMed 

Google Scholar 

Gibson, C. M. et al. Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N. Engl. J. Med. 375, 2423–2434 (2016).

Article 
CAS 
PubMed 

Google Scholar 

Cannon, C. P. et al. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N. Engl. J. Med. 377, 1513–1524 (2017).

Article 
CAS 
PubMed 

Google Scholar 

Kumbhani, D. J. et al. 2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention or with atherosclerotic cardiovascular disease: a report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. 77, 629–658 (2021).

Article 
PubMed 

Google Scholar 

Angiolillo, D. J. et al. Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American Perspective: 2021 update. Circulation 143, 583–596 (2021).

Article 
CAS 
PubMed 

Google Scholar 

Schaefer, J. K. et al. Adverse events associated with the addition of aspirin to direct oral anticoagulant therapy without a clear indication. JAMA Intern. Med. 181, 817–824 (2021).

Article 
CAS 
PubMed 

Google Scholar 

Schaefer, J. K. et al. Association of adding aspirin to warfarin therapy without an apparent indication with bleeding and other adverse events. JAMA Intern. Med. 179, 533–541 (2019).

Article 
PubMed 
PubMed Central 

Google Scholar 

Akao, M. et al. Rivaroxaban monotherapy versus combination therapy according to patient risk of stroke and bleeding in atrial fibrillation and stable coronary disease: AFIRE trial subanalysis. Am. Heart J. 236, 59–68 (2021).

Article 
CAS 
PubMed 

Google Scholar 

Gragnano, F. et al. P2Y₁₂ inhibitor or aspirin monotherapy for secondary prevention of coronary events. J. Am. Coll. Cardiol. 82, 89–105 (2023).

Article 
CAS 
PubMed 

Google Scholar 

Patti, G. et al. Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy – a pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries. Int. J. Cardiol. 270, 160–166 (2018).

Article 
PubMed 

Google Scholar 

Yasuda, S. et al. Antithrombotic therapy for atrial fibrillation with stable coronary disease. N. Engl. J. Med. 381, 1103–1113 (2019).

Article 
CAS 
PubMed 

Google Scholar 

US National Library of Medicine. ClinicalTrials.gov http://www.clinicaltrials.gov/ct2/show/NCT05627375 (2023).

CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348, 1329–1339 (1996).

Article 

Google Scholar 

Bhatt, D. L., Hirsch, A. T., Ringleb, P. A., Hacke, W. & Topol, E. J. Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators. Am. Heart J. 140, 67–73 (2000).

Article 
CAS 
PubMed 

Google Scholar 

McQuaid, K. R. & Laine, L. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am. J. Med. 119, 624–638 (2006).

Article 
CAS 
PubMed 

Google Scholar 

Wallentin, L. et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 361, 1045–1057 (2009).

Article 
CAS 
PubMed 

Google Scholar 

Wiviott, S. D. et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 357, 2001–2015 (2007).

Article 
CAS 
PubMed 

Google Scholar 

Hiatt, W. R. et al. Ticagrelor versus clopidogrel in symptomatic peripheral artery disease. N. Engl. J. Med. 376, 32–40 (2017).

Article 
CAS 
PubMed 

Google Scholar 

Hochholzer, W. et al. Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38 (TRITON-TIMI 38). Circulation 123, 2681–2689 (2011).

Article 
PubMed 

Google Scholar 

Guo, C. G. et al. Systematic review with meta-analysis: the risk of gastrointestinal bleeding in patients taking third-generation P2Y₁₂ inhibitors compared with clopidogrel. Aliment. Pharmacol. Ther. 49, 7–19 (2019).

Article 
CAS 
PubMed 

Google Scholar 

Koo, B. K. et al. Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial. Lancet 397, 2487–2496 (2021).

Article 
CAS 
PubMed 

Google Scholar 

Nguyen, T. A., Diodati, J. G. & Pharand, C. Resistance to clopidogrel: a review of the evidence. J. Am. Coll. Cardiol. 45, 1157–1164 (2005).

Article 
CAS 
PubMed 

Google Scholar 

Giugliano, R. P. et al. Edoxaban versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 369, 2093–2104 (2013).

Article 
CAS 
PubMed 

Google Scholar 

Patel, M. R. et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N. Engl. J. Med. 365, 883–891 (2011).

Article 
CAS 
PubMed 

Google Scholar 

Connolly, S. J. et al. Dabigatran versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 361, 1139–1151 (2009).

Article 
CAS 
PubMed 

Google Scholar 

Schulman, S. et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N. Engl. J. Med. 361, 2342–2352 (2009).

Article 
CAS 
PubMed 

Google Scholar 

Schulman, S. et al. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. Circulation 129, 764–772 (2014).

Article 
CAS 
PubMed 

Google Scholar 

Agnelli, G. et al. Oral apixaban for the treatment of acute venous thromboembolism. N. Engl. J. Med. 369, 799–808 (2013).

Article 
CAS 
PubMed 

Google Scholar 

Young, A. M. et al. Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D). J. Clin. Oncol. 36, 2017–2023 (2018).

Article 
CAS 
PubMed 

Google Scholar 

Raskob, G. E. et al. Edoxaban for the treatment of cancer-associated venous thromboembolism. N. Engl. J. Med. 378, 615–624 (2018).

Article 
CAS 
PubMed 

Google Scholar 

Agnelli, G. et al. Apixaban for the treatment of venous thromboembolism associated with cancer. N. Engl. J. Med. 382, 1599–1607 (2020).

Article 
CAS 
PubMed 

Google Scholar 

Halvorsen, S. et al. Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis. Eur. Heart J. 38, 1455–1462 (2017).

CAS 
PubMed 

Google Scholar 

Gralnek, I. M. et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 47, a1–a46 (2015).

Article 
PubMed 

Google Scholar 

Ray, W. A. et al. Association of proton pump inhibitors with reduced risk of warfarin-related serious upper gastrointestinal bleeding. Gastroenterology 151, 1105–1112.e10 (2016).

Article 
CAS 
PubMed 

Google Scholar 

Sung, J. J. et al. Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018. Gut 67, 1757–1768 (2018).

Article 
PubMed 

Google Scholar 

Qureshi, W. et al. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation. Am. J. Cardiol. 113, 662–668 (2014).

Article 
CAS 
PubMed 

Google Scholar 

Gralnek, I. M. et al. Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) guideline – update 2021. Endoscopy 53, 300–332 (2021).

Article 
PubMed 

Google Scholar 

Gralnek, I. M. et al. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 54, 1094–1120 (2022).

Article 
PubMed 

Google Scholar 

Sung, J. J. et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann. Intern. Med. 152, 1–9 (2010).

Article 
PubMed 

Google Scholar 

Forrest, J. A., Finlayson, N. D. & Shearman, D. J. Endoscopy in gastrointestinal bleeding. Lancet 2, 394–397 (1974). Aug 17.

Article 
CAS 
PubMed 

Google Scholar 

de Groot, N. L. et al. Reassessment of the predictive value of the Forrest classification for peptic ulcer rebleeding and mortality: can classification be simplified? Endoscopy 46, 46–52 (2014).

PubMed 

Google Scholar 

Sherwood, M. W. et al. Gastrointestinal bleeding in patients with atrial fibrillation treated with rivaroxaban or warfarin: ROCKET AF trial. J. Am. Coll. Cardiol. 66, 2271–2281 (2015).

Article 
CAS 
PubMed 

Google Scholar 

Aisenberg, J. et al. Gastrointestinal bleeding with edoxaban versus warfarin: results from the ENGAGE AF-TIMI 48 trial (effective anticoagulation with factor Xa next generation in atrial fibrillation-thrombolysis in myocardial infarction). Circ. Cardiovasc. Qual. Outcomes 11, e003998 (2018).

Article 
PubMed 

Google Scholar 

Garcia, D. A. et al. Gastrointestinal bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Am. Heart J. 221, 1–8 (2020).

Article 
CAS 
PubMed 

Google Scholar 

Witt, D. M. et al. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch. Intern. Med. 172, 1484–1491 (2012).

Article 
CAS 
PubMed 

Google Scholar 

Little, D. H. W. et al. Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding. CMAJ 193, E304–E309 (2021).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Little, D. et al. Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: a systematic review and meta-analysis. Thromb. Res. 175, 102–109 (2019).

Article 
CAS 
PubMed 

Google Scholar 

Candeloro, M. et al. Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: communication from the ISTH SSC Subcommittee on Control of Anticoagulation. J. Thromb. Haemost. 19, 2618–2628 (2021).

Article 
CAS 
PubMed 

Google Scholar 

Staerk, L. et al. Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study. BMJ 351, h5876 (2015).

Article 
PubMed 
PubMed Central 

Google Scholar 

Little, D. H. W. et al. Management of antithrombotic therapy after gastrointestinal bleeding: a mixed methods study of health-care providers. J. Thromb. Haemost. 19, 153–160 (2021).

Article 
PubMed 

Google Scholar 

Nieto, J. A. et al. Acute venous thromboembolism in patients with recent major bleeding. The influence of the site of bleeding and the time elapsed on outcome. J. Thromb. Haemost. 4, 2367–2372 (2006).

Article 
CAS 
PubMed 

Google Scholar 

Burnett, A. E. & Barnes, G. D. A call to action for anticoagulation stewardship. Res. Pract. Thromb. Haemost. 6, e12757 (2022).

Article 
PubMed 
PubMed Central 

Google Scholar 

Capodanno, D. et al. Bleeding avoidance strategies in percutaneous coronary intervention. Nat. Rev. Cardiol. 19, 117–132 (2022).

Article 
PubMed 

Google Scholar 

Angiolillo, D. J. et al. Pharmacokinetic and pharmacodynamic profile of a novel phospholipid aspirin formulation. Clin. Pharmacokinet. 61, 465–479 (2022).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Cryer, B. et al. Low-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trial. Am. J. Gastroenterol. 106, 272–277 (2011).

Article 
CAS 
PubMed 

Google Scholar 

Storey, R. F. et al. Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes. Eur. Heart J. 41, 3132–3140 (2020).

Article 
CAS 
PubMed 

Google Scholar 

Bhatt, D. L. et al. Antibody-based ticagrelor reversal agent in healthy volunteers. N. Engl. J. Med. 380, 1825–1833 (2019).

Article 
CAS 
PubMed 

Google Scholar 

Gurbel, P. A., Bliden, K. P., Chaudhary, R. & Tantry, U. S. First in-human experience with inhaled acetylsalicylic acid for immediate platelet inhibition: comparison with chewed and swallowed acetylsalicylic acid. Circulation 142, 1305–1307 (2020).

Article 
CAS 
PubMed 

Google Scholar 

Vivas, D. et al. Effects of intravenous lysine acetylsalicylate versus oral aspirin on platelet responsiveness in patients with ST-segment elevation myocardial infarction: the ECCLIPSE-STEMI trial. J. Thromb. Thrombolysis 55, 203–210 (2023).

Article 
CAS 
PubMed 

Google Scholar 

Parodi, G. et al. Orodispersible ticagrelor in acute coronary syndromes: the TASTER study. J. Am. Coll. Cardiol. 78, 292–294 (2021).

Article 
CAS 
PubMed 

Google Scholar 

Rai, V., Balters, M. W. & Agrawal, D. K. Factors IX, XI, and XII: potential therapeutic targets for anticoagulant therapy in atherothrombosis. Rev. Cardiovasc. Med. 20, 245–253 (2019).

Article 
PubMed 

Google Scholar 

Nickel, K. F., Long, A. T., Fuchs, T. A., Butler, L. M. & Renné, T. Factor XII as a therapeutic target in thromboembolic and inflammatory diseases. Arterioscler. Thromb. Vasc. Biol. 37, 13–20 (2017).

Article 
CAS 
PubMed 

Google Scholar 

Nopp, S., Kraemmer, D. & Ay, C. Factor XI inhibitors for prevention and treatment of venous thromboembolism: a review on the rationale and update on current evidence. Front. Cardiovasc. Med. 9, 903029 (2022).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

De Caterina, R., Prisco, D. & Eikelboom, J. W. Factor XI inhibitors: cardiovascular perspectives. Eur. Heart J. 44, 280–292 (2023).

Article 
PubMed 

Google Scholar 

Bikdeli, B. et al. Sulodexide versus control and the risk of thrombotic and hemorrhagic events: meta-analysis of randomized trials. Semin. Thromb. Hemost. 46, 908–918 (2020).

Article 
CAS 
PubMed 

Google Scholar 

Chan, F. K. L. et al. Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines. Gut 67, 405–417 (2018).

Article 
CAS 
PubMed 

Google Scholar 

Uchiyama, S., Tanahashi, N. & Minematsu, K. Clopidogrel two doses comparative 1-year assessment of safety and efficacy (COMPASS) study in Japanese patients with ischemic stroke. Cerebrovasc. Dis. 34, 229–239 (2012).

Article 
CAS 
PubMed 

Google Scholar 

Becker, R. C. et al. Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the Platelet Inhibition and Patient Outcomes (PLATO) trial. Eur. Heart J. 32, 2933–2944 (2011).

Article 
CAS 
PubMed 

Google Scholar 

Granger, C. B. et al. Apixaban versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 365, 981–992 (2011).

Article 
CAS 
PubMed 

Google Scholar